GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Short Ratio

Indivior (Indivior) Short Ratio


View and export this data going back to 2014. Start your Free Trial

What is Indivior Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Indivior (Indivior) Business Description

Traded in Other Exchanges
Address
234 Bath Road, Slough, Berkshire, GBR, SL1 4EE
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Indivior (Indivior) Headlines

From GuruFocus

Indivior Announces H1 and Q2 2022 Financial Results

By PRNewswire PRNewswire 07-28-2022

Indivior Announces Q1 2023 Financial Results

By PRNewswire PRNewswire 04-27-2023

Indivior To Participate In Upcoming Investor Conferences

By PRNewswire PRNewswire 05-25-2023

Indivior To Acquire Opiant Pharmaceuticals

By PRNewswire PRNewswire 11-14-2022

Indivior Announces Q3 2022 Financial Results

By PRNewswire PRNewswire 10-27-2022

Indivior Completes Acquisition of Opiant Pharmaceuticals, Inc.

By PRNewswire PRNewswire 03-02-2023

Indivior Announces Q3 2023 Financial Results

By PRNewswire 11-14-2023